CLINICAL_TRIALS
trial_result
· 2020-11-12
Clinical Trial Update: Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma [Phase 2]
Summary
Phase 2 trial of pembrolizumab in advanced hepatocellular carcinoma completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lynn Feun, MD | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2020-11-12